SCHEMBL23978728

SCHEMBL23978728

NC(=O)NC[C@H](N)C(=O)OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.49
SLC6A2 P23975 1/20 0.49
SLC6A3 Q01959 1/20 0.49
KMT2A Q03164 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
SLC1A3 P43003 1/20 0.48
SLC1A1 P43005 1/20 0.48
IDO1 P14902 1/20 0.46
ALDH1A1 P00352 3/20 0.46
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPK1 P28482 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TSHR P16473 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
POLB P06746 1/20 0.44
PLAU P00749 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29398484 0.88 SLC1A3 (0.58) SLC6A2SLC6A3KMT2ATDP1SLC1A3
SCHEMBL5555264 0.85 KMT2A (0.53) SLC6A2SLC6A3KMT2ATDP1SLC1A3
SCHEMBL12757430 0.84 MAPT (0.49) SLC6A2SLC6A3KMT2ATDP1SLC1A3
SCHEMBL23978690 0.83 ALDH1A1 (0.49) BCAT2SLC6A2SLC6A3KMT2ATDP1
SCHEMBL8695483 0.83 ALDH1A1 (0.51) SLC6A2SLC6A3KMT2ATDP1SLC1A3
SCHEMBL598314 0.82 DPP8 (0.52) SLC6A2SLC6A3KMT2ATDP1SLC1A3
SCHEMBL598313 0.82 DPP8 (0.52) SLC6A2SLC6A3KMT2ATDP1SLC1A3
SCHEMBL23489415 0.81 ALDH1A1 (0.44) SLC6A2SLC6A3KMT2ATDP1SLC1A3
Trifluoroacetic Acid SCHEMBL20263694 0.80 SLC1A3 (0.51) KMT2ASLC1A3SLC1A1LMNASMN1; SMN2
SCHEMBL17878732 0.80 SYK (0.65) KMT2ASLC1A3SLC1A1IDO1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222789-A1 INHIBITORS OF ALPHA 2 BETA 1 INTEGRIN AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-11-04 WO disclosed